KURA
KURA
US50127T1097
Kura Oncology, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 67.482.000 53.883.000
25.2%
Cost of Revenue 57.000 --
--
Gross Profit 67.425.000 53.883.000
25.1%
371.056.000 247.078.000
50.2%
Operating Income -303.631.000 -193.195.000
57.2%
Pretax Income -278.369.000 -171.965.000
61.9%
Net Income Common Stockholders -278.666.000 -173.983.000
60.2%
-- --
--
-- --
--
ende